Pharmacy

Aerie Pharmaceuticals to be sold for $770M

Alcon, a Switzerland-based eye care company, is teed up to acquire Durham, N.C.-based Aerie Pharmaceuticals for about $770 million after approval from each company’s board of directors Aug. 22.

By: Paige Twenter

Tuesday, August 23rd, 2022

Aerie Pharmaceuticals specializes in testing, manufacturing and selling eye treatments.

Pending stockholder approval, the transaction is expected to finalize in the fourth quarter of 2022, according to a news release.

Next Up in Pharmacy

Baptist Health pharmacy braces for tech, policy shifts

As regulatory pressure mounts and workforce shortages persist, Louisville, Ky.-based Baptist Health System is positioning pharmacy as a safeguard for…

By: Ella Jeffries
13 hours ago
10 hospitals, health systems seeking pharmacy leaders

The following hospitals and health systems have recently posted job listings for pharmacy leaders. Note: This is not an exhaustive…

By: Ella Jeffries
14 hours ago
8 drugs in shortage

Here are eight recent drug shortages and discontinuations, according to the FDA’s drug supply databases:

By: Ella Jeffries
14 hours ago

Comments are closed.

Stop the $1.2M bleed: A proven roadmap to physician retention

Next Up in Pharmacy

Baptist Health pharmacy braces for tech, policy shifts

10 hospitals, health systems seeking pharmacy leaders

8 drugs in shortage

Join the 500,000+ healthcare executives who start their day with Becker’s